The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.
However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape.
Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers.
Speaking at a Politico health care policy forum, CMS Administrator Mehmet Oz, MD, said he supports Medicaid, adding that “when you love something, you protect it.”
The insurance giant has been piloting a program to speed up reimbursement to hospitals in 10 states, reducing delays by roughly 50%. Now, the company said it will work to lift prior authorization barriers on patient care delivery. The intent is to roll out these changes nationwide by the end of 2026, UnitedHealthcare confirmed.
By and large, U.S. hospitals and health systems do not have an AI adoption problem. But many—if not most—have an execution problem: They struggle to turn a set of installed AI tools into a measurable operational value.
